NCT05508750View on ClinicalTrials.gov

Growth and Safety Clinical Trial on a New Infant Formula

NACompletedINTERVENTIONAL

Enrollment

420

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

January 2, 2024

Study Completion Date

January 2, 2024

Conditions

Weight Gain

Interventions

OTHER

New Infant Formula

New infant formula fed daily ad libitum

OTHER

Commercial Infant Formula

Commercially available infant formula fed daily ad libitum

Trial Locations (1)

10001

ObvioHealth, New York

All Listed Sponsors

collaborator

IQVIA RDS Inc.

INDUSTRY

collaborator

ObvioHealth

INDUSTRY

lead

Jovie USA, LLC

INDUSTRY